Guiping Wan

456 total citations
28 papers, 336 citations indexed

About

Guiping Wan is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Immunology. According to data from OpenAlex, Guiping Wan has authored 28 papers receiving a total of 336 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Reproductive Medicine, 16 papers in Obstetrics and Gynecology and 9 papers in Immunology. Recurrent topics in Guiping Wan's work include Endometriosis Research and Treatment (16 papers), Uterine Myomas and Treatments (10 papers) and Endometrial and Cervical Cancer Treatments (8 papers). Guiping Wan is often cited by papers focused on Endometriosis Research and Treatment (16 papers), Uterine Myomas and Treatments (10 papers) and Endometrial and Cervical Cancer Treatments (8 papers). Guiping Wan collaborates with scholars based in China, Australia and Mexico. Guiping Wan's co-authors include Tao Gui, Xiaodong Han, Yabing Chen, Xiaoming Yao, Jing Wang, Huixian Chen, Peng Cao, Shuxia Wang, Weiwei Tang and Jiaming Zhang and has published in prestigious journals such as Cell Death and Differentiation, Gene and Journal of Cerebral Blood Flow & Metabolism.

In The Last Decade

Guiping Wan

25 papers receiving 328 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guiping Wan China 10 136 131 111 82 81 28 336
Lih-Yuh C. Wing Taiwan 8 85 0.6× 263 2.0× 203 1.8× 39 0.5× 207 2.6× 11 459
Ouping Huang China 11 154 1.1× 113 0.9× 63 0.6× 72 0.9× 64 0.8× 26 317
Klaudia Klicka Poland 9 165 1.2× 74 0.6× 23 0.2× 136 1.7× 58 0.7× 11 324
Michiya Noguchi Japan 7 199 1.5× 314 2.4× 176 1.6× 48 0.6× 88 1.1× 22 494
Qiaoying Lv China 12 81 0.6× 75 0.6× 85 0.8× 38 0.5× 62 0.8× 24 275
Yuanxi Zhu China 6 152 1.1× 61 0.5× 99 0.9× 92 1.1× 33 0.4× 8 364
Abdulkhaliq Alsaadi United Kingdom 4 134 1.0× 56 0.4× 12 0.1× 75 0.9× 43 0.5× 6 245
Junde Zhao China 8 159 1.2× 36 0.3× 21 0.2× 113 1.4× 81 1.0× 14 304
C.M.G. Thomas United Kingdom 5 104 0.8× 47 0.4× 18 0.2× 64 0.8× 27 0.3× 8 316

Countries citing papers authored by Guiping Wan

Since Specialization
Citations

This map shows the geographic impact of Guiping Wan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guiping Wan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guiping Wan more than expected).

Fields of papers citing papers by Guiping Wan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guiping Wan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guiping Wan. The network helps show where Guiping Wan may publish in the future.

Co-authorship network of co-authors of Guiping Wan

This figure shows the co-authorship network connecting the top 25 collaborators of Guiping Wan. A scholar is included among the top collaborators of Guiping Wan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guiping Wan. Guiping Wan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Fangfang, Lin Gan, Guiping Wan, et al.. (2025). Serum 2-miRNA panel as a non-invasive diagnostic biomarker for adenomyosis. Gene. 970. 149777–149777.
2.
Wang, Qing, Boyang Liu, Qi Chen, et al.. (2025). A real-world retrospective cohort study: the clinical outcomes and characteristics of platinum-resistant recurrent ovarian cancer. Translational Cancer Research. 14(5). 3161–3174.
3.
Chen, Danfei, Qin Zhang, Yan Yan, et al.. (2025). Efficacy and safety of Kunxinning granules in patients with menopausal syndrome: a multicenter, randomized, double-blinded, and placebo-controlled trial. Frontiers in Pharmacology. 16. 1512110–1512110.
4.
Qian, Cheng, Ying Huang, Shan Zhang, et al.. (2025). Integrated identification and mechanism exploration of bioactive ingredients from Salvia miltiorrhiza to induce vascular normalization. Phytomedicine. 138. 156427–156427. 3 indexed citations
6.
Li, Jue, Zin‐An Wu, Nan Li, et al.. (2025). Exploring macrophage and nerve interaction in endometriosis-associated pain: the inductive role of IL-33. Inflammation Research. 74(1). 42–42. 3 indexed citations
8.
Wan, Guiping, et al.. (2024). Macrophage polarization in adenomyosis: A review. American Journal of Reproductive Immunology. 91(4). e13841–e13841. 5 indexed citations
9.
Xu, Chengshi, Donghu Yu, Zhiyu Li, et al.. (2024). Anti-tumor effects of telmisartan in glioma-astrocyte non-contact co-cultures: A critical role of astrocytic IL-6-mediated paracrine growth promotion. International Immunopharmacology. 139. 112707–112707. 2 indexed citations
10.
Wang, Jia‐Yi, et al.. (2024). Primary culture of endometrial mesenchymal stem cells derived from ectopic lesions of patients with adenomyosis. Archives of Gynecology and Obstetrics. 310(6). 3239–3253. 1 indexed citations
12.
Gui, Tao, Ming Liu, Bing Yao, et al.. (2021). TCF3 is epigenetically silenced by EZH2 and DNMT3B and functions as a tumor suppressor in endometrial cancer. Cell Death and Differentiation. 28(12). 3316–3328. 33 indexed citations
13.
Chen, Yabing, et al.. (2019). Endometriotic Peritoneal Fluid Promotes Myofibroblast Differentiation of Endometrial Mesenchymal Stem Cells. Stem Cells International. 2019. 1–13. 16 indexed citations
14.
Cheng, Xiaolan, et al.. (2016). Wenshen Xiaozheng Tang induces apoptosis and inhibits migration of ectopic endometriotic stromal cells. Journal of Ethnopharmacology. 194. 386–394. 8 indexed citations
15.
Wan, Guiping, et al.. (2014). Serum microRNA-205 as a novel biomarker for cervical cancer patients. Cancer Cell International. 14(1). 81–81. 46 indexed citations
16.
Gui, Tao, Chen Chen, Weiwei Tang, et al.. (2013). The disturbance of TH17-Treg cell balance in adenomyosis. Fertility and Sterility. 101(2). 506–514. 27 indexed citations
17.
Hu, Chunping, et al.. (2013). Therapeutic Potential of Wenshen Xiaozheng Tang, a Traditional Chinese Medicine Prescription, for Treating Endometriosis. Reproductive Sciences. 20(10). 1215–1223. 8 indexed citations
18.
Tang, Weiwei, et al.. (2013). Wenshen Xiaozheng Tang suppresses the growth of endometriosis with an antiangiogenic effect. Climacteric. 16(6). 700–708. 10 indexed citations
19.
Tang, Weiwei, Zhenzhen Zhang, Hongmei Yao, Zheng Zeng, & Guiping Wan. (2013). Papillary serous carcinoma of the cervix mixed with squamous cells: A report of the first case. PubMed. 6. 22–24. 7 indexed citations
20.
Gao, Jian, Xueting Cai, Wuguang Lu, et al.. (2011). Immunological regulation of Chinese herb Guizhi Fuling Capsule on rat endometriosis model. Journal of Ethnopharmacology. 134(3). 624–629. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026